ESC 365 - Translating data to practice: aspirin in high-risk patient subgroups

ESC Premium Access

Translating data to practice: aspirin in high-risk patient subgroups

Event: ESC CONGRESS 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Sponsored by Bayer AG

Date: 2 September 2019

Time: 13:00 - 14:00

Session

5 presentations in this session

Welcome and introduction

Speaker: Professor P. Henry (Paris, FR)

Aspirin in patients with diabetes: primary prevention, secondary prevention or both?

Speaker: Professor U. Laufs (Leipzig, DE)

Speaker: Doctor F. Andreotti (Rome, IT)

Summary

Speaker: Professor P. Henry (Paris, FR)

Looking beyond patient age: the role of aspirin in cardiovascular risk management

Speaker: Doctor F. Andreotti (Rome, IT)

Speaker: Professor U. Laufs (Leipzig, DE)

Closing remarks

Speaker: Professor M. Gaziano (Boston, US)

7 speakers from this session

Professor Patrick Henry

AP-HP - Hospital Lariboisiere, Paris (France)

2 presentations

0 follower

Professor Ulrich Laufs

Leipzig University Hospital, Leipzig (Germany)

27 presentations

0 follower

Doctor Felicita Andreotti

Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Rome (Italy)

19 presentations

0 follower

Professor Patrick Henry

AP-HP - Hospital Lariboisiere, Paris (France)

2 presentations

0 follower

Doctor Felicita Andreotti

Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Rome (Italy)

19 presentations

0 follower

Professor Ulrich Laufs

Leipzig University Hospital, Leipzig (Germany)

27 presentations

0 follower

Professor Mike Gaziano

, Boston (United States of America)

2 presentations

0 follower

This platform is supported by